Andreas Seidl
Chief Tech/Sci/R&D Officer at FORMYCON AG
Network origin in Andreas Seidl first degree
Entity | Entity type | Industry | |
---|---|---|---|
10
| Public Company | Pharmaceuticals: Major | 10 |
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.
8
| Holding Company | Medical/Nursing Services | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andreas Seidl via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Eon Labs, Inc.
Eon Labs, Inc. Pharmaceuticals: MajorHealth Technology Eon Labs, Inc. manufactures pharmaceuticals and generic drugs. They produce drugs in oral dosage variety and in both immediate and extended release delivery systems. Their products are used in treating arthritis, ulcers, epilepsy, infections and obsessive-compulsive disorder. The company was founded in 1992 and is headquartered in Lake Success, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chief Tech/Sci/R&D Officer | |
THERADIAG | Medical Specialties | Director/Board Member | |
Université Libre de Bruxelles | College/University | Doctorate Degree | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
DMS IMAGING | Biotechnology | Director/Board Member | |
Université Catholique de Louvain | College/University | Doctorate Degree | |
Henogen SA
Henogen SA Pharmaceuticals: MajorHealth Technology Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Okairos AG
Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
NANOREPRO AG | Hospital/Nursing Management | Founder | |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
European Vaccine Initiative
European Vaccine Initiative BiotechnologyHealth Technology The European Vaccine Initiative manufactures vaccines. The private company is based in London, UK. | Biotechnology | Corporate Officer/Principal | |
ImmuneHealth ASBL
ImmuneHealth ASBL Medical/Nursing ServicesHealth Services develops vaccines to cure disorders of the immune system. Its services include preclinical evaluation, clinical immunomonitoring, technical transfer, consulting and training services, cell, gene, and protein readout development, and clinical biomarker panels validation. The company was founded in 2007 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Director/Board Member | |
Q-Biologicals NV
Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
alphablom AG | Chairman | ||
finanzpark AG
finanzpark AG Commercial Printing/FormsCommercial Services Finanzpark AG provides newsletter and financial reports publishing services. The private company is based in Nuremberg, Germany. | Commercial Printing/Forms | Director/Board Member | |
4 for Cells SRL
4 for Cells SRL Data Processing ServicesTechnology Services 4 for Cells SPRL provides business outsourcing services. The private company is based in Hastière, Belgium. The Belgian company was founded in 2011. François Lesage has been the CEO of the company since 2011. | Data Processing Services | Director/Board Member | |
Eurobiotech SA | Director/Board Member | ||
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
Duke University School of Medicine | College/University | Doctorate Degree | |
ABIVAX | Pharmaceuticals: Other | Director/Board Member | |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Univac NV | Director/Board Member | ||
Thémis SA | Director/Board Member | ||
balandis real estate AG
balandis real estate AG Real Estate DevelopmentFinance balandis real estate AG engages in the acquisition, management, value enhancement, and sale of real estate properties. It focuses on commercial properties such as offices and retail stores. The company was founded on December 23, 2013 and is headquartered in Gräfelfing, Germany. | Real Estate Development | Chief Executive Officer | |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
BodenWert Immobilien AG
BodenWert Immobilien AG Real Estate DevelopmentFinance BodenWert Immobilien AG operates as a real estate investment firm, which specializes in property and corporate financing. It also engages in the acquisition, development, and renovation of land and real estate assets. The company is headquartered in Munich, Germany. | Real Estate Development | Director/Board Member | |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Director/Board Member | |
Paedi Protect AG
Paedi Protect AG Specialty StoresRetail Trade Paedi Protect AG develops, manufactures, and markets medical skin care products for babies and children. The company was founded by Olaf Stiller and Gerald Rehor in July 2013 and is headquartered in Marburg, Germany. | Specialty Stores | Chief Executive Officer | |
R3 Capital GmbH | Corporate Officer/Principal | ||
Ncardia SA
Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
AOC Value SAS | Corporate Officer/Principal | ||
AOC Technology SAS
AOC Technology SAS Financial ConglomeratesFinance Part of Active Ownership Corp SARL, AOC Technology SAS is an investment holding Luxembourger company. The company is based in Luxembourg, Luxembourg. | Financial Conglomerates | Corporate Officer/Principal | |
AOC Health Holdco SARL | Corporate Officer/Principal | ||
Active Ownership Corp SARL
Active Ownership Corp SARL Investment ManagersFinance Active Ownership Corp SARL provides investment advice. The private company is based in Grevenmacher, Luxembourg. and has subsidiaries in Luxembourg. The Luxembourger company was founded by Florian M. Schuhbauer, Klaus Röhrig. | Investment Managers | Founder | |
Exceet Management SARL | Corporate Officer/Principal | ||
BioTec CCI AG | Director/Board Member | ||
Deutsche Kosmetikwerke AG | Chief Executive Officer | ||
ARTCLINE GmbH
ARTCLINE GmbH BiotechnologyHealth Technology ARTCLINE GmbH is a German biotechnology company that focuses on developing diagnostic and therapeutic procedures for intensive care medicine. The private company is located in Germany. | Biotechnology | Chief Executive Officer | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
DNAlytics SA
DNAlytics SA Data Processing ServicesTechnology Services DNAlytics SA engages in the development of data-driven precision medicine solutions. The firm provides consultancy services; and academic medical, biological, and clinical research laboratories for the pharmaceutical, biotechnology and In-Vitro Diagnostic companies. It also offers software programs unde rthe REED, LiblineaR, jForest, and BLISS brands. The company was founded by Pierre Dupont and Thibault Helleputte in 2012 and is headquartered in Louvain-la-Neuve, Belgium. | Data Processing Services | Director/Board Member |
Statistics
International
Belgium | 18 |
Germany | 16 |
Luxembourg | 6 |
France | 5 |
Switzerland | 5 |
Sectoral
Health Technology | 23 |
Finance | 6 |
Consumer Services | 4 |
Commercial Services | 4 |
Health Services | 3 |
Operational
Director/Board Member | 86 |
Chief Executive Officer | 38 |
Corporate Officer/Principal | 35 |
Chairman | 16 |
Founder | 15 |
Most connected contacts
Insiders | |
---|---|
Jean-Paul Prieels | 32 |
Gerhard Ries | 27 |
Klaus Röhrig | 22 |
Andreas Rummelt | 18 |
Thomas Strüngmann | 16 |
Frank Mathias | 15 |
Enno Spillner | 13 |
Olaf Stiller | 12 |
Peter Wendeln | 6 |
Wolfgang Schwandner | 4 |
Stefan Glombitza | 4 |
Wolfgang Essler | 4 |
Harald Mosler | 3 |
Nicola Mikulcik Ohrner | 3 |
Jens Altrichter | 2 |
- Stock Market
- Insiders
- Andreas Seidl
- Company connections